Literature DB >> 22825408

Prevalence and associations of retinal vein occlusions: the Central India Eye and Medical Study.

Jost B Jonas1, Vinay Nangia, Anshu Khare, Ajit Sinha, Sarang Lambat.   

Abstract

PURPOSE: To determine the prevalence of retinal vein occlusions (RVOs) in rural central India.
METHODS: The population-based Central India Eye and Medical Study was performed in rural central India and included 4,711 subjects (30 years and older). Using fundus photographs, we assessed the prevalence of branch retinal vein occlusions and central retinal vein occlusions.
RESULTS: An RVO was detected in 38 eyes (0.42 ± 0.07%; 95% confidence interval: 0.29-0.56) of 35 subjects (0.76 ± 0.13%; 95% confidence interval: 0.50-1.01). Prevalence of branch retinal vein occlusions was 0.66% ± 0.12% per subject (95% confidence interval: 0.42%-0.90%) and of central retinal vein occlusions was 0.11% ± 0.05% per subject (95% confidence interval: 0.01%-0.21%). In binary logistic analysis, presence of RVOs was associated with higher age (P = 0.007), systolic blood pressure (P < 0.001), blood concentration of urea (P = 0.02), and narrower anterior chamber angle (P < 0.03). The RVO prevalence was not significantly (all Ps > 0.10) associated with body mass index; blood concentrations of glucose, cholesterol, high-density lipoproteins, and creatinine; presence of diabetes mellitus, tuberculosis and malaria; nutritional parameters; alcohol consumption; refractive error; and optic disk size. The age-specific prevalence rates of RVOs were 0.18% ± 0.13%, 0.29% ± 0.15%, 0.89% ± 0.34%, 1.07% ± 0.36%, 2.72% ± 0.85%, and 3.64% ± 2.55%, respectively, for decadal age groups. In two (5%) eyes, RVO had caused low vision (visual acuity <20/60 and ≥20/400).
CONCLUSION: In the rural agrarian low-income population of Central India, RVOs were detected in 0.8% of adults, with branch retinal vein occlusions being approximately seven times more common than central retinal vein occlusions. Main associated factors were higher age, blood pressure, urea blood concentration, and narrow chamber angle. RVOs were no major reason for visual impairment.

Entities:  

Mesh:

Year:  2013        PMID: 22825408     DOI: 10.1097/IAE.0b013e318260246f

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  8 in total

1.  FELLOW EYE CHANGES IN PATIENTS WITH NONISCHEMIC CENTRAL RETINAL VEIN OCCLUSION: Assessment of Perfused Foveal Microvascular Density and Identification of Nonperfused Capillaries.

Authors:  Alexander Pinhas; Michael Dubow; Nishit Shah; Eric Cheang; Chun L Liu; Moataz Razeen; Alexander Gan; Rishard Weitz; Yusufu N Sulai; Toco Y Chui; Alfredo Dubra; Richard B Rosen
Journal:  Retina       Date:  2015-10       Impact factor: 4.256

2.  Results from the Population-Based Gutenberg Health Study Revealing Four Altered Autoantibodies in Retinal Vein Occlusion Patients.

Authors:  Katharina Bell; Vanessa M Beutgen; Stefan Nickels; Katrin Lorenz; Yvonne Scheller; Hisham Elbaz; Tunde Peto; Katharina A Ponto; Andreas Schulz; Philipp S Wild; Thomas Münzel; Karl J Lackner; Irene Schmidtmann; Manfred Beutel; Norbert Pfeiffer; Franz H Grus; Alexander K Schuster
Journal:  J Ophthalmol       Date:  2020-07-29       Impact factor: 1.909

3.  Effect of posterior sub-tenon triamcinolone in macular edema due to non-ischemic vein occlusions.

Authors:  Murali Mohan Gurram
Journal:  J Clin Diagn Res       Date:  2013-09-13

4.  Central retinal vein occlusion and pseudoexfoliation syndrome.

Authors:  Dimitrios Karagiannis; Georgios A Kontadakis; Nektarios E Klados; Ioannis Tsoumpris; Artemios S Kandarakis; Efstratios A Parikakis; Ilias Georgalas; Miltiadis K Tsilimbaris
Journal:  Clin Interv Aging       Date:  2015-05-20       Impact factor: 4.458

5.  Prevalence and associated factors of retinal vein occlusion in the Korean National Health and Nutritional Examination Survey, 2008-2012: A cross-sectional observational study.

Authors:  Yong Un Shin; Heeyoon Cho; Jong Min Kim; Kunho Bae; Min Ho Kang; Jae Pil Shin; Eunwoo Nam; Se Woong Kang
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

6.  A Multicenter, Retrospective Study (RE-ENACT 2) on Razumab™ (World's First Biosimilar Ranibizumab) in Retinal Vein Occlusion.

Authors:  Shashikant Sharma; Mujtaba Khan; Alok Chaturvedi
Journal:  Ophthalmol Ther       Date:  2020-07-02

7.  Sub-optimal gain in vision in retinal vein occlusion due to under-treatment in the real world: results from an open-label prospective study of Intravitreal Ranibizumab.

Authors:  Raja Narayanan; Aditya Kelkar; Zahir Abbas; Neha Goel; Manoj Soman; Naveen Naik; Aditya Sudhalkar; Jaydeep Walinjkar; Utkarsh Shah; Nitin Maksane
Journal:  BMC Ophthalmol       Date:  2021-01-12       Impact factor: 2.209

8.  Prevalence of Retinal Vein Occlusions and Estimated Cerebrospinal Fluid Pressure: The Kailuan Eye Study.

Authors:  Qian Wang; Jingyan Yang; Jost B Jonas; Xuehui Shi; Shouling Wu; Shuohua Chen; Yanni Yan; Wenjia Zhou; Li Dong; Wenbin Wei; Ya Xing Wang
Journal:  Eye Brain       Date:  2021-05-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.